Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study
BackgroundAlthough a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates ex...
| Հիմնական հեղինակներ: | , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Frontiers Media S.A.
2022-11-01
|
| Շարք: | Frontiers in Cardiovascular Medicine |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full |